Detroit wins bid for big Caraco expansion

On the heels of winning FDA approval for its generic version of the type 2 diabetes drug Prandin, Caraco Pharmaceutical Laboratories announced a big expansion of its Detroit facilities, creating 600 jobs over the next five years and boosting pill production by 40 percent to 5 billion per year.

Majority owned by Sun Pharmaceuticals of India, Caraco now employs 455 people. It considered expanding in the Carolinas instead--both states aggressively wooed the company--but opted to grow in Detroit after Michigan's governor offered tuition-free job training at community colleges and technical schools.

- see the release on the approval
- here's the report from The Detroit Free Press

Suggested Articles

It’s final: England won’t be covering AZ’s quick-selling Tagrisso in previously untreated non-small cell lung cancer patients with EGFR mutatations.

Top J&J meds have managed to hang onto market share in the face of new generics and biosims, but the drugmaker expects the pain to continue in 2020.

Lonza’s search for a new CEO is expected to be wrapped up this year as the CDMO homes in on a list of veterans from outside the company.